Clinical Trial Update: Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting a single ascending dose study of GGF2 in patients with left ventricular dysfunction and symptomatic heart failure; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• GGF2 (glial growth factor 2)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Heart Failure | Phase 1 | Status: COMPLETED | Results posted: 2014-07-01